These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19305633)

  • 1. Novel approaches to smoothing and comparing SELDI TOF spectra.
    Meleth S; Eltoum IE; Zhu L; Oelschlager D; Piyathilake C; Chhieng D; Grizzle WE
    Cancer Inform; 2005; 1(1):78-85. PubMed ID: 19305633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis.
    Zhang G; Zhou B; Zheng Y; Feng K; Rao L; Zhang J; Xin J; Zhang B; Zhang L
    Int J Cardiol; 2009 Jan; 131(2):225-33. PubMed ID: 18180059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.
    Schlichtemeier SM; Nahm CB; Xue A; Gill AJ; Smith RC; Hugh TJ
    J Surg Res; 2019 Jun; 238():127-136. PubMed ID: 30771682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
    Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spectral Smoothing with Adaptive Multiscale Window Average].
    Ji J; Gao PF; Jia NN; Yang R; Guo HM; Hu Q; Zhuang SL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2015 May; 35(5):1445-9. PubMed ID: 26415477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia].
    Giacomelli C; Bazzichi L; Giusti L; Ciregia F; Baldini C; Da Valle Y; De Feo F; Sernissi F; Rossi A; Bombardieri S; Lucacchini A
    Reumatismo; 2011 Nov; 63(3):165-70. PubMed ID: 22257917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
    Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
    Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
    Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
    Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra.
    Carlson SM; Najmi A; Whitin JC; Cohen HJ
    Proteomics; 2005 Jul; 5(11):2778-88. PubMed ID: 15986333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annotated regions of significance of SELDI-TOF-MS spectra for detecting protein biomarkers.
    Tan CS; Ploner A; Quandt A; Lehtiö J; Pernemalm M; Lewensohn R; Pawitan Y
    Proteomics; 2006 Dec; 6(23):6124-33. PubMed ID: 17072907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.
    Hegmans JP; Veltman JD; Fung ET; Verch T; Glover C; Zhang F; Allard WJ; T'Jampens D; Hoogsteden HC; Lambrecht BN; Aerts J
    Technol Cancer Res Treat; 2009 Oct; 8(5):323-32. PubMed ID: 19754208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in protein profiles of the isolates of Entamoeba histolytica and E. dispar by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) ProteinChip assays.
    Makioka A; Kumagai M; Kobayashi S; Takeuchi T
    Parasitol Res; 2007 Dec; 102(1):103-10. PubMed ID: 17846790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of algorithms for pre-processing of SELDI-TOF mass spectrometry data.
    Cruz-Marcelo A; Guerra R; Vannucci M; Li Y; Lau CC; Man TK
    Bioinformatics; 2008 Oct; 24(19):2129-36. PubMed ID: 18694894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis.
    Cui JF; Liu YK; Zhou HJ; Kang XN; Huang C; He YF; Tang ZY; Uemura T
    World J Gastroenterol; 2008 Feb; 14(8):1257-62. PubMed ID: 18300354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.
    Skytt A; Thysell E; Stattin P; Stenman UH; Antti H; Wikström P
    Int J Cancer; 2007 Aug; 121(3):615-20. PubMed ID: 17410539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.